Uncategorized

Immune Checkpoint Inhibitors Market, Global Outlook and Forecast 2022-2028

Immune checkpoints are proteins that play an important role in regulating the immune system. In cancer, the immune checkpoints are activated to suppress the anti-tumor activity of the immune system thereby suppressing the immune response against the cancer cells. The study of these proteins and pathways has led to the development of a number of immune checkpoint inhibitors as therapies against cancer. Initial preclinical studies showed that antibody blockade of the immune checkpoint molecule CTLA-4 resulted in successful anti-tumor immune responses in the murine cancer models. This was then followed by studies targeting the PD-1/PD-L1 pathway. Ipilimumab and Yervoy were the first immune checkpoint inhibitors introduced in the market. With the promising results of Yervoy, several anti-PD-1 and anti-PD-L1 antibodies have been developed. Although there are number of other checkpoints that have been studied, such as LAG-3 and TIM-3, the only approved immune checkpoint inhibitors include CTLA-4, PD-1 and PD-L1.

This report contains market size and forecasts of Immune Checkpoint Inhibitors in global, including the following market information:

Global Immune Checkpoint Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)

Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/7202794/global-immune-checkpoint-inhibitors-forecast-2022-2028-319

Global Immune Checkpoint Inhibitors Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Immune Checkpoint Inhibitors companies in 2021 (%)

The global Immune Checkpoint Inhibitors market was valued at 12910 million in 2021 and is projected to reach US$ 35160 million by 2028, at a CAGR of 15.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

PD-1/PD-L1 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Immune Checkpoint Inhibitors include Bristol Myer Squibb, AstraZeneca, Merck, Roche / Genentech, Ono Pharmaceutical, Regeneron, Innovent, Hengrui Medicine and Junshi Biosciences. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Immune Checkpoint Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Immune Checkpoint Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Immune Checkpoint Inhibitors Market Segment Percentages, by Type, 2021 (%)

PD-1/PD-L1

CTLA-4

Global Immune Checkpoint Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Immune Checkpoint Inhibitors Market Segment Percentages, by Application, 2021 (%)

Lung Cancer

Colorectal Cancer

Breast Cancer

Prostate Cancer

Melanoma

Blood Cancer

Other

Global Immune Checkpoint Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Immune Checkpoint Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Immune Checkpoint Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Immune Checkpoint Inhibitors revenues share in global market, 2021 (%)

Key companies Immune Checkpoint Inhibitors sales in global market, 2017-2022 (Estimated), (MT)

Key companies Immune Checkpoint Inhibitors sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Bristol Myer Squibb

AstraZeneca

Merck

Roche / Genentech

Ono Pharmaceutical

Regeneron

Innovent

Hengrui Medicine

Junshi Biosciences

Table of content

1 Introduction to Research & Analysis Reports
1.1 Immune Checkpoint Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune Checkpoint Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immune Checkpoint Inhibitors Overall Market Size
2.1 Global Immune Checkpoint Inhibitors Market Size: 2021 VS 2028
2.2 Global Immune Checkpoint Inhibitors Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Immune Checkpoint Inhibitors Sales: 2017-2028
3 Company Landscape
3.1 Top Immune Checkpoint Inhibitors Players in Global Market
3.2 Top Global Immune Checkpoint Inhibitors Companies Ranked by Revenue
3.3 Global Immune Checkpoint Inhibitors Revenue by Companies
3.4 Global Immune Checkpoint Inhibitors Sales by Companies
3.5 Global Immune Checkpoint Inhibitors Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Immune Checkpoint Inhibitors Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Immune Checkpoint Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immune Checkpoint Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 Immune Checkpoint Inhibitors Companies
3.8.2 List of Glob

 

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Visit: https://www.statsmarketresearch.com/
Similar Reports: Global Immune Checkpoint Inhibitors Market Research Report 2022 Professional Edition

Global Immune Checkpoint Inhibitors Market Insights, Forecast to 2028

2022-2027 Global and Regional Immune Checkpoint Inhibitors Industry Status and Prospects Professional Market Research Report Standard Version

Global Immune Checkpoint Inhibitors Market Research Report 2022 Professional Edition
 

Related Articles

Back to top button